UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 14A
                PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                            (AMENDMENT NO. 2)

Filed by the Registrant [  ]
Filed by a Party other than the Registrant [X ]
Check the appropriate box:

[  ]     Preliminary Proxy Statement

[  ]     CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE
         14A-6(E)(2))

[  ]     Definitive Proxy Statement

[  ]     Definitive Additional Materials

[X ]     Soliciting Material Pursuant to  240.14a-12


                         COMPETITIVE TECHNOLOGIES, INC.
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE
    (NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)

Payment of Filing Fee (Check the appropriate box):

[X ]     No fee required.

[  ]    Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     (1)     Title of each class of securities to which transaction applies:

     (2)     Aggregate number of securities to which transaction applies:

     (3)     Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):

     (4)     Proposed maximum aggregate value of transaction:

     (5)     Total fee paid:

[  ]     Fee paid previously with preliminary materials.

[  ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.

     (1)     Amount Previously Paid:


     (2)     Form, Schedule or Registration Statement No.:

     (3)     Filing Party:


     (4)     Date Filed:




                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE

                              AN URGENT MESSAGE TO
                   COMPETITIVE TECHNOLOGIES, INC. STOCKHOLDERS

     We believe Competitive Technologies is out of control; losses are mounting,
conflicts  have  divided  management  and the stock price has plummeted.  In our
opinion,  Competitive  Technologies'  viability  as  a  public  company is being
seriously  threatened  under  current  management.

     These conflicts include many matters which will be detailed in our upcoming
proxy  materials,  including  problems  with  substantial  and often unnecessary
litigation,  substantial  increases  in  executive compensation while faced with
increasing  losses  and  diminishing  stockholder  value, failure to produce new
revenue streams, substantial stock dilution, failure to honor contracts and many
other  matters.

     While  John  Nano  served  as  Chief  Executive  Officer  and  President of
Competitive  Technologies  from  2002  to  2005,  our  loyal  team  relentlessly
identified  growth  opportunities  that  drove  profitability  and value for our
shareholders.  Our efforts succeeded as earnings rose $9.7 million over a period
of  three  years.   Our  management  team  achieved  three  consecutive years of
significant  profit  improvements,  reaching  $5.7  million in fiscal 2005.  Our
record  revenue  and  profit growth resulted in the Company being the fourteenth
largest  percentage gaining stock in 2004 as reported by the Wall Street Journal
with  an  increase  share  price  of  345%.

     Unfortunately,  our  team's strong profitability for CTT was converted into
corporate  and  shareholder losses by the current Board and management after the
Board  changed  management  17  months  ago.  At  that  time, the success of our
management  was  reflected  in  CTT stock prices over $10 per share.  During the
tenure of and because of actions by the current Board, 80% of CTT's stock market
value  has  been  destroyed.

     On  the  watch  of  the current Board and management, shareholder value was
squandered  even  as the overall stock market performs at record levels.  In the
recently  announced  fiscal  year  2006 results, revenues were reduced by nearly
$9.0  million  (or  63%), and earnings by $8.1 million under CTT's current Board
and  management.  The  current  Board and management presided over a reversal of
CTT's  fortunes  from  a  2005  profit  of about $5.7 million, to a 2006 loss of
nearly  $2.4  million  this  year.  The  $8.1 million reversal under the current
Board  and  management,  from  strong profitability to appalling losses, had the
predictable  effect  of cratering CTT's stock price.  CTT's Board and management
have  recorded  losses  every  quarter  after  they  changed  management.

     To restore our Company's profitability and shareholder value, we are firmly
committed  to  the  replacement  of  the  Board  of  Directors and return of our
successful  management  team.  WE  WILL  SOON  BE  MAILING TO YOU PROXY MATERIAL
SOLICITING  YOUR  PROXY TO ELECT A SLATE OF DIRECTORS IN OPPOSITION TO THE SLATE



PROPOSED  BY  THE  EXISTING  MANAGEMENT  GROUP.  Our proxy will describe what we
believe  are  the failures of the current management.  It will also describe the
extensive qualifications of our slate of candidates, whom we believe will return
to  CTT  substantial  experience  in  the Company's business, a successful track
record  in  managing  growth and serious management expertise through our legacy
team.  Our  team  urgently  asks  for  your support as a shareholder, advisor or
broker  to restore the Company to profitability, to drive growth and to increase
shareholder  value.

     Please  refrain  from voting any proxy sent to you by the management of CTT
until  you  have  had the opportunity to consider our material.  ALTHOUGH WE ARE
NOT  YET  SOLICITING  YOUR PROXY, WE ARE ANXIOUS TO HEAR YOUR VIEWS.  PLEASE USE
THE  COUPON  BELOW  TO  SHARE  WITH  US  YOUR  CONCERNS ABOUT THE COMPANY.  This
information  will  not  be  used  for  any  other  purpose.

     Thank  you  in  advance for your consideration to restore CTT to the bright
future  our Company enjoyed under our past stewardship and will again enjoy upon
our  return  to  CTT.

                         Sincerely,
                         THE  COMMITTEE  TO  RESTORE  STOCKHOLDER  VALUE

                         John  B.  Nano,  Committee  Member and Director Nominee


TO:  THE  COMMITTEE  TO  RESTORE  STOCKHOLDER  VALUE
     C/O  CUTLER  LAW  GROUP
     3206  WEST  WIMBLEDON  DRIVE
     AUGUSTA,  GA  30909
     FAX:  (706)  738-1966
     EMAIL:  RCUTLER@CUTLERLAW.COM

     Name___________:_____________________________________________________

     Stockholder  [ ] of  record  or  [ ] in  street  name

     Brokerage  firm  holding  your  shares ______________________________

     Number  of  Competitive  Technologies  Shares  Held _________________

     Your  telephone  number  (day)(___)_________  (night) (___)__________

     We  appreciate  your comments:________________________________________

     ______________________________________________________________________

     ______________________________________________________________________

     ______________________________________________________________________

WE ARE NOT CURRENTLY ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US
                              A PROXY AT THIS TIME.




                             INFORMATION CONCERNING
                   THE COMMITTEE TO RESTORE STOCKHOLDER VALUE

The  Committee  is  comprised of the former Chief Executive of the Company, John
Nano,  as  well as Ben Marcovitch, William L. Reali and Richard D. Hornidge, Jr.
Specific  information  with respect to each of these members of the Committee is
set  forth  below:

     JOHN  B. NANO, 62, the President and Chief Executive Officer who we believe
was  forced  out  seventeen  months  ago by the Board, would return as Director,
President  and  Chief  Executive  Officer.  Mr.  Nano  was  President  and Chief
Executive  Officer  of  Competitive Technologies, Inc. from June 2002 until June
2005.  Since  his removal by the existing Board, in January 2006 Mr. Nano become
President  and  Chief  Executive  Officer  of  Articulated Technologies, LLC., a
company  involved  in creating and commercializing patented light emitting diode
technologies for global solid state lighting applications.  Mr. Nano also served
as  Chief  Financial Officer of Competitive Technologies from August 2003 to May
2004.  From  2000 to 2001, he served as a Principal reporting to the Chairman of
Stonehenge  Network  Holdings,  N.V., a global virtual private network provider,
with  respect  to  certain  operating, strategic planning and finance functions.
From  1998  to  1999,  Mr.  Nano  served  as  Executive Vice President and Chief
Financial  Officer  of ConAgra Trade Group, Inc., a subsidiary of ConAgra, Inc.,
an  international  food company.  From 1993 to 1998, he served as Executive Vice
President  and  Chief  Financial  Officer  of  Sunkyong  America,  the  American
subsidiary  of  the  Sunkyong  Group, a Korean conglomerate, and President of an
Internet  Startup  Division  of  Sunkyong  America.  Mr.  Nano owns 22 shares of
Competitive  Technologies,  Inc.  stock  and  has  an  option to purchase 75,000
additional  shares  which is presently disputed by the Company. After the change
in  management,  Mr.  Nano intends to buy additional shares in the company as he
previously did when he was President and Chief Executive Officer.  Mr. Nano owns
22  shares of Competitive Technologies, Inc. stock and has an option to purchase
75,000  additional shares which is presently disputed by the Company . After the
change  in  management, Mr. Nano intends to buy additional shares in the company
as  he  previously  did  when  he  was  President  and  Chief Executive Officer.

     We  strongly believe the current Board terminated Mr. Nano in June 2005 for
his  refusal to certify the Chief Executive Officer certification required under
Sarbanes-Oxley  legislation  disclosure  requirements  due  to  insider  trading
allegations.  The  minutes  written  by the Company of the Board Meeting on June
14,  2005  state that Mr. Nano was terminated by the current Board.  The minutes
were  presented  by  the  Company  and  are  part  of the evidence in Mr. Nano's
litigation  in  Connecticut Superior Court.  Mr. Nano was terminated on June 14,
2005,  the  last  day  for  the  Company  to  file  the  Chief Executive Officer
Certification  required  under Sarbanes-Oxley legislation.  Mr. Nano had refused
to  sign  unless  the allegations of insider trading were cured and disclosed to
the  shareholders.  Mr.  Nano  was  terminated by the Board on June 14, 2005 and
Donald  Freed  was  appointed  Chief Executive Officer.  Donald Freed signed the
certification  without  any  disclosures of the insider trading allegations that
were  under  investigation  and  of  serious  concern  to  Mr.  Nano.



     As  set  forth in more detail below, Mr. Nano has a lawsuit pending against
Competitive  Technologies  in  United States District Court, for the District of
Connecticut  alleging  the  Company  violated  the  Sarbanes-Oxley legislation's
whistleblower  protection.  Prior  to  his  termination,  Mr.  Nano  and  others
expressed serious concerns of insider trading activities to John Sabin, Chairman
of the Audit Committee of the Board, other members of the Board, lawyers for the
Company  including  Chris  Robertson of Seyfarth Shaw LLP, attorney John Sten at
Greenberg & Traurig, and also advised the Securities Exchange CommissionMr. Nano
has  evidence  of  these insider trading activities that include testimony under
oath  from  Richard  Carver,  Chairman of the Board.  The Committee will provide
upon request written transcripts of Richard Carver's testimony which he provided
under  oath  in  Connecticut  Superior Court, before Judge Lewis on November 14,
2005.  On  that  transcript on page 173 (lines 18 thru 27) and page 174 (lines 1
thru  14) Richard Carver testifies that he told Donald Freed and others in early
April  that  he  was  going  to terminate John Nano.  After having received that
inside  information,  only days later on April 27 and 28, 2005 Donald Freed sold
all  of  his  available  shares  and  options for Competitive Technologies stock
including  all  shares  owned, all vested options and all 401(k) shares.  Donald
Freed's  stock  sales  were reported to the SEC on filings on Form 4 and are all
available  on  the  SEC  Edgar system.  The termination of Mr. Nano was not made
public  by  Competitive Technologies until June 14, 2005 after the market closed

     This and other evidence of insider trading caused Mr. Nano serious concerns
about violations of SEC regulations and fraud against shareholders by members of
the  Board  of  the Company.  We believe that Mr. Nano was terminated because he
voiced  those concerns and emailed those concerns to John Sabin, Chairman of the
Audit Committee and voiced those concerns to lawyers for Seyfarth Shaw including
Chris  Robertson.

     BEN  MARCOVITCH,  72,  will  be  elected as a Director of the Company.  Mr.
Marcovitch  has  over  50  years  of  in-depth  experience in corporate finance,
financial reporting, and compliance matters.  From 2004 through the present, Mr.
Marcovitch  has been a financial advisor for AgroFrut E.U., a company located in
Cali,  Columbia involved in fruit processing for nutriceutical operations.  From
July  2002  to  October  2003  Mr. Marcovitch was President of DDS Technologies,
Inc.,  and  became Chairman and Chief Executive Oficer of DDS Technologies, Inc.
in  October  2003 where he remained until April 2004.  DDS Technologies, Inc. is
an  international  venture capital and corporate management company with several
offices  in two countries.  From 2000 to 2001, Mr. Marcovitch was a Director and
Chairman  of  the  Board  of  Findex.com,  Inc.,  a  developer,  publisher  and
distributor  of  Christian  faith-based  software  products  to  individuals and
religious  organizations.  Mr.  Marcovitch is not presently a stockholder of the
Company.  Mr.  Marcovitch  is  not  presently  a  stockholder  of  the  Company.



     WILLIAM  L.  REALI,  64, will be elected as a Director of the Company.  Mr.
Reali  is  a  Certified  Public Accountant with the firm of Reali, Giampetro and
Scott  in Canfield, Ohio.  The firm provides accounting, tax and consulting to a
variety  of  business  clients.  Mr.  Reali's primary experience during the past
five  years  has  been  in  business  consulting.  Mr.  Reali is not presently a
stockholder  of  the  Company.  Mr.  Reali is not presently a stockholder of the
Company.

     RICHARD D. HORNIDGE, Jr., 60, will be elected as a Director of the Company.
Mr.  Hornidge  is  a  long  time  and  respected  stockholder  of  Competitive
Technologies,  and  owner  of  62,000  shares of Competitive Technologies common
stock,  which is more shares than ANY of the existing management of the Company.
Since  February  2005,  Mr.  Hornidge  has been a tennis professional at Willows
Racquet Club in North Andover, Massachusetts.  From June 1984 through June 1989,
Mr.  Hornidge  was  President  of  Travis Associates, an employment agency.  Mr.
Hornidge was a program coordinator for Raytheon from 1973 through 1984, where he
was  involved  in  the  Patriot  Missile  test  equipment  program.

     JOEL M. EVANS, M.D., 46, will be elected as a Director of the Company.  Dr.
Evans  founded  The  Center  for Women's Health in Stamford, Connecticut in June
1996,  and since then has been its Director.  From November 1996 to present, Dr.
Evans  has been a lecturer and senior faculty member of The Center for Mind Body
Medicine  in  Washington, D.CDr. Evans has been featured in magazines as well as
interviewed  on  television  and radio shows across the country. Dr. Evans is an
Assistant  Clinical  Professor at the Albert Einstein College of Medicine in New
York  City  and  helped  create  a clinical study at Columbia University Medical
Center  for  use of the herb, black cohosh, in breast cancer. From November 2005
to  present,  Dr.  Evans  has been a member of the Scientific Advisory Board for
Metagenics  Incorporated,  a  nutritional  supplement  manufacturer.  Dr.  Evans
brings  key nutriceutical experience to the Company.  Dr. Evans is not presently
a  stockholder  of  the  Company.

     RALPH  S.  TORELLO,  68, will be elected as a Director of the Company.  For
the  past  five  years, Mr. Torello has been an independent financial consultant
advising  various  companies  on their financial strategies.  Included among the
companies  that  Mr.  Torello  has  performed  consulting services are Goodnight
Audio,  a full service recording studio, Patriot American Mortgage, a commercial
and  home  mortgage company, DDS Technologies, Inc., an organic waste processor,
Coit Medical, a medical accessory marketer and other miscellaneous companies and
individuals.  Mr.  Torello  is  not  presently  a  stockholder  of  the Company.



STOCKHOLDERS OF COMPETITIVE TECHNOLOGIES ARE ADVISED TO READ THE PROXY STATEMENT
OF  THE  COMMITTEE  TO RESTORE STOCKHOLDER VALUE WHEN IT IS AVAILABLE BECAUSE IT
WILL  CONTAIN  IMPORTANT  INFORMATION.  STOCKHOLDERS  MAY  OBTAIN A COPY OF SUCH
PROXY  STATEMENT  FROM  THE WEBSITE OF THE SECURITIES AND EXCHANGE COMMISSION AT
WWW.SEC.GOV.  STOCKHOLDERS  MAY  ALSO OBTAIN A COPY OF SUCH PROXY STATEMENT FROM
THE  COMMITTEE WITHOUT CHARGE BY WRITING TO THE COMMITTEE TO RESTORE STOCKHOLDER
VALUE,  C/O CUTLER LAW GROUP, 3206 WEST WIMBLEDON DRIVE, AUGUSTA, GEORGIA 30909.